Cite
Zhou K, Liu Y, Yuan Q, et al. Next-Generation Sequencing-Based Analysis of Urine Cell-Free mtDNA Reveals Aberrant Fragmentation and Mutation Profile in Cancer Patients. Clin Chem. 2022;doi: 10.1093/clinchem/hvab268.
Zhou, K., Liu, Y., Yuan, Q., Lai, D., Guo, S., Wang, Z., Su, L., Zhang, H., Wang, X., Guo, W., Ji, X., Gu, X., Huang, Q., Guo, X., & Xing, J. (2022). Next-Generation Sequencing-Based Analysis of Urine Cell-Free mtDNA Reveals Aberrant Fragmentation and Mutation Profile in Cancer Patients. Clinical chemistry, . https://doi.org/10.1093/clinchem/hvab268
Zhou, Kaixiang, et al. "Next-Generation Sequencing-Based Analysis of Urine Cell-Free mtDNA Reveals Aberrant Fragmentation and Mutation Profile in Cancer Patients." Clinical chemistry vol. (2022). doi: https://doi.org/10.1093/clinchem/hvab268
Zhou K, Liu Y, Yuan Q, Lai D, Guo S, Wang Z, Su L, Zhang H, Wang X, Guo W, Ji X, Gu X, Huang Q, Guo X, Xing J. Next-Generation Sequencing-Based Analysis of Urine Cell-Free mtDNA Reveals Aberrant Fragmentation and Mutation Profile in Cancer Patients. Clin Chem. 2022 Jan 05; doi: 10.1093/clinchem/hvab268. Epub 2022 Jan 05. PMID: 34993545.
Copy
Download .nbib